• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio?

    6/23/24 11:43:47 AM ET
    $ACN
    $ADSK
    $CELH
    $CHWY
    Real Estate
    Real Estate
    Computer Software: Prepackaged Software
    Technology
    Get the next $ACN alert in real time by email

    These large-cap stocks were the best performers in the last week. Are they in your portfolio?

    1. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares increased 29.50% after the company announced FDA approval of an expansion to the labeled indication for ELEVIDYS to include individuals with Duchenne muscular dystrophy with a confirmed mutation in the DMD gene who are at least 4 years of age. Also, multiple firms raised their respective price targets on the stock.
    2. Sirius XM Holdings Inc. (NASDAQ:SIRI) shares gained 16.73% in the last week.
    3. Toast, Inc. (NYSE:TOST) shares upped 15.57% in the last week.
    4. Gilead Sciences, Inc. (NASDAQ:GILD) shares were up 12.62% on continued strength following positive Phase 3 HIV data.
    5. Chewy, Inc. (NYSE:CHWY) stock jumped 10.59%. The stock may be up after retail purchases at online outlets rose in May.
    6. Accenture Plc (NYSE:ACN) stock increased 9.80% after the company reported third quarter results. Several analysts cut their price forecasts.
    7. DraftKings Inc (NASDAQ:DKNG) shares advanced 9.69% in the last week. This surge comes on the heels of a pivotal decision by the U.S. Supreme Court that has significant implications for the future of online sports betting in Florida and optimism that taxes will not be introduced into New Jersey's 2025 budget, which needs to be finalized by June 30.
    8. Dell Inc (NYSE:DELL) shares gained 8.19% in the last week after Elon Musk said the company is assembling half of the racks that are going into the supercomputer that xAI is building.
    9. Autodesk Inc (NASDAQ:ADSK) shares gained 7.99% following a report suggesting that Starboard has a $500 million stake in the company.
    10. Gold Fields Limited (NYSE:GFI) shares rose 7.15%. Shares of gold stocks are trading higher amid a rise in the price of gold.

    Photo via Shutterstock

    Get the next $ACN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACN
    $ADSK
    $CELH
    $CHWY

    CompanyDatePrice TargetRatingAnalyst
    Gilead Sciences Inc.
    $GILD
    3/10/2026$180.00Buy
    Jefferies
    Autodesk Inc.
    $ADSK
    3/2/2026$343.00 → $279.00Market Perform
    BMO Capital Markets
    Celsius Holdings Inc.
    $CELH
    2/27/2026$65.00Underperform → Buy
    BofA Securities
    Cheniere Energy Inc.
    $LNG
    2/27/2026$250.00 → $255.00Buy
    TD Cowen
    Cheniere Energy Inc.
    $LNG
    2/24/2026$236.00Overweight → Equal-Weight
    Morgan Stanley
    Gilead Sciences Inc.
    $GILD
    2/20/2026$155.00Equal Weight
    Barclays
    Chewy Inc.
    $CHWY
    2/19/2026$28.00Mkt Perform → Outperform
    Raymond James
    Accenture plc
    $ACN
    2/17/2026$275.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $ACN
    $ADSK
    $CELH
    $CHWY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Estepan Ian Michael covered exercise/tax liability with 1,097 shares, decreasing direct ownership by 0.54% to 201,983 units (SEC Form 4)

    4 - Sarepta Therapeutics, Inc. (0000873303) (Issuer)

    3/13/26 8:09:03 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Wong Ryan Ho-Yan covered exercise/tax liability with 256 shares, decreasing direct ownership by 0.19% to 135,064 units (SEC Form 4)

    4 - Sarepta Therapeutics, Inc. (0000873303) (Issuer)

    3/13/26 8:07:03 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President, R&D and Tech Ops Rodino-Klapac Louise covered exercise/tax liability with 948 shares, decreasing direct ownership by 0.42% to 225,323 units (SEC Form 4)

    4 - Sarepta Therapeutics, Inc. (0000873303) (Issuer)

    3/13/26 8:05:03 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACN
    $ADSK
    $CELH
    $CHWY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Accenture Announces Reinvention Services Leadership

    Accenture (NYSE:ACN) today announced its new leadership team for Reinvention Services, which is led by Manish Sharma, Accenture's Chief Strategy and Services Officer. These leaders are part of the company's implementation of a new design for Reinvention Services that will enable Accenture to create more leading solutions faster and embed data and AI more easily into its solutions and delivery. These changes are effective March 31, 2026. Accenture is organizing its services around how its clients operate and will bring its clients end-to-end solutions, including with its ecosystem, through seven units called Reinvention Partners. Reinvention Partners are responsible for helping clients rei

    3/13/26 9:29:00 AM ET
    $ACN
    Real Estate

    Udacity, Part of Accenture, Launches Accredited MBA to Train the Next Generation of AI Product Leaders

    Groundbreaking program can be completed for less than $5,000, democratizing access to one of the most in-demand roles in the AI economy Hands-on curriculum includes courses on AI transformation, business intelligence, growth marketing, and more Udacity, part of Accenture LearnVantage (NYSE:ACN) and the leading provider of tech skills for the AI economy, today announced the launch of a fully accredited Master of Business Administration degree program designed specifically for the next generation of AI product leaders. While traditional MBAs have long held a direct path into product management, they often lack the hands-on, technical training required in today's AI-driven economy. Th

    3/12/26 8:59:00 AM ET
    $ACN
    Real Estate

    Accenture Helps Organizations Strengthen Cloud Security with Google Cloud

    Cloud security further enhanced as Accenture continues its existing collaboration with Wiz, recently acquired by Google Cloud Accenture (NYSE:ACN) today announced an expansion of its strategic partnership with Google Cloud to help organizations stay ahead of escalating AI-driven cyber threats, from hyper-personalized social engineering to autonomous malware. The collaboration helps better deliver unified, intelligence-led cyber defense by combining the Google Security Operations platform and Accenture's global cybersecurity services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311727909/en/Accenture today announced an ex

    3/11/26 5:29:00 PM ET
    $ACN
    Real Estate

    $ACN
    $ADSK
    $CELH
    $CHWY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Farrell Matthew bought $464,814 worth of shares (5,000 units at $92.96), increasing direct ownership by 86% to 10,820 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    2/23/26 4:07:34 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Sloan Harry bought $2,185,000 worth of shares (100,000 units at $21.85), increasing direct ownership by 40% to 350,219 units (SEC Form 4)

    4 - DraftKings Inc. (0001883685) (Issuer)

    2/18/26 9:16:04 AM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Director Kravitz Hal bought $452,400 worth of shares (10,000 units at $45.24), increasing direct ownership by 5% to 216,147 units (SEC Form 4)

    4 - Celsius Holdings, Inc. (0001341766) (Issuer)

    11/17/25 5:00:10 PM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    $ACN
    $ADSK
    $CELH
    $CHWY
    SEC Filings

    View All

    SEC Form 144 filed by DraftKings Inc.

    144 - DraftKings Inc. (0001883685) (Subject)

    3/13/26 12:22:41 PM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 144 filed by Toast Inc.

    144 - Toast, Inc. (0001650164) (Subject)

    3/12/26 11:11:19 AM ET
    $TOST
    EDP Services
    Technology

    SEC Form 144 filed by DraftKings Inc.

    144 - DraftKings Inc. (0001883685) (Subject)

    3/11/26 4:07:05 PM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ACN
    $ADSK
    $CELH
    $CHWY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-6) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/25/2024. Application Category: NDA, Application Number: 215973, Application Classification: Efficacy

    11/26/24 4:36:21 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-8) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/25/2024. Application Category: NDA, Application Number: 215974, Application Classification: Efficacy

    11/26/24 4:36:21 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-9) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/13/2024. Application Category: NDA, Application Number: 215973, Application Classification: Manufacturing (CMC)

    11/15/24 4:36:27 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACN
    $ADSK
    $CELH
    $CHWY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies initiated coverage on Gilead Sciences with a new price target

    Jefferies initiated coverage of Gilead Sciences with a rating of Buy and set a new price target of $180.00

    3/10/26 8:40:41 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BMO Capital Markets reiterated coverage on Autodesk with a new price target

    BMO Capital Markets reiterated coverage of Autodesk with a rating of Market Perform and set a new price target of $279.00 from $343.00 previously

    3/2/26 8:16:50 AM ET
    $ADSK
    Computer Software: Prepackaged Software
    Technology

    Celsius upgraded by BofA Securities with a new price target

    BofA Securities upgraded Celsius from Underperform to Buy and set a new price target of $65.00

    2/27/26 8:20:43 AM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    $ACN
    $ADSK
    $CELH
    $CHWY
    Financials

    Live finance-specific insights

    View All

    SIRIUSXM ANNOUNCES EXPIRATION AND RESULTS OF CASH TENDER OFFER FOR ANY AND ALL OUTSTANDING 3.125% SENIOR NOTES DUE 2026

    NEW YORK, March 5, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASDAQ:SIRI) ("SiriusXM") announced today that the cash tender offer (the "Offer"), commenced on February 26, 2026, by its subsidiary, Sirius XM Radio LLC (the "Offeror"), to purchase any and all of the Offeror's outstanding 3.125% Senior Notes due 2026 (the "Notes"), expired at 5:00 p.m. New York City time on March 4, 2026 (the "Expiration Time"). According to Kroll Issuer Services (US), the tender and information agent for the Offer, valid tenders had been received at the expiration of the Offer in the amount and percentage set forth in the table below.Issuer‌     Title of Security‌     CUSIPNumbers(2)‌     Principal Amount O

    3/5/26 8:30:00 AM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    SIRIUSXM ANNOUNCES PRICING TERMS OF CASH TENDER OFFER FOR ANY AND ALL OUTSTANDING 3.125% SENIOR NOTES DUE 2026

    NEW YORK, March 4, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASDAQ:SIRI) ("SiriusXM") announced today the pricing terms of the previously announced cash tender offer (the "Offer") by its subsidiary, Sirius XM Radio LLC (the "Offeror"), to purchase any and all of the Offeror's outstanding 3.125% Senior Notes due 2026 (the "Notes"). The Offer is made pursuant to an Offer to Purchase and a related Notice of Guaranteed Delivery, each dated February 26, 2026, which set forth the complete terms and conditions of the Offer. Certain information regarding the Notes and the terms of the Offer is summarized in the table below.IssuerTitle of SecurityCUSIPNumbers(2)Principal Amount OutstandingU.S. T

    3/4/26 12:50:00 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    Accenture to Announce Second-Quarter Fiscal 2026 Results

    Accenture Schedules Second-Quarter Fiscal 2026 Earnings Call Accenture (NYSE:ACN) will host a conference call at 8:00 a.m. EDT on Thursday, March 19, 2026, to discuss its second-quarter fiscal 2026 financial results. An earnings news release will be issued before the call. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303434979/en/ To participate in the teleconference, please dial +1 (877) 883-0383 [+1 (412) 317-6061 outside the U.S., Puerto Rico and Canada] and enter access code 7353716 approximately 15 minutes before the scheduled start of the call. The conference call will also be accessible live via webcast on the In

    3/3/26 6:59:00 AM ET
    $ACN
    Real Estate

    $ACN
    $ADSK
    $CELH
    $CHWY
    Leadership Updates

    Live Leadership Updates

    View All

    Arkansas Winner Sets New Jackpocket Record, Wins $250.8 Million Powerball® Jackpot From Ticket Ordered Using Jackpocket App

    Today, Jackpocket announced that a $250.8 million winning ticket was ordered using Jackpocket, America's No. 1 lottery courier app*. The lucky winner ordered the ticket in Arkansas and matched all winning numbers during Monday night's Powerball drawing – 2, 17, 18, 38, 62 – plus the Powerball® (20). This was only the winner's second order using the Jackpocket app. "We're thrilled for our customer in Arkansas and amazed that just their second order placed with Jackpocket resulted in a life-changing $250.8 million jackpot — setting a new Jackpocket record," said Pete Sullivan, SVP, Lottery at DraftKings. "This historic win underscores our commitment to delivering a best-in-class, secure, an

    3/4/26 10:05:00 AM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Agentic AI Foundation Welcomes 97 New Members As Demand for Open, Collaborative Agent Standardization Increases

    Industry leading organizations unite under neutral Foundation led by new governing board chair David Nalley to support the future of interoperable AISummaryAgentic AI Foundation (AAIF) appoints David Nalley as governing board chair, and welcomes 18 new Gold Members and 79 new Silver Members.Under the AAIF, members help to reduce fragmentation in the ecosystem, improve interoperability, shape standards and advance open protocols.New Gold Members include industry leaders Akamai, American Express, Autodesk, Circle, Diagrid, Equinix, Global Payments, Hitachi, Huawei, Infobip, JPMorgan Chase, Keycard, Lenovo, Red Hat, ServiceNow, TELUS, UiPath and Workato.NAPA, Calif., Feb. 24, 2026 /PRNewswire/

    2/24/26 12:00:00 PM ET
    $ADSK
    $AXP
    $CRCL
    Computer Software: Prepackaged Software
    Technology
    Finance: Consumer Services
    Finance

    Chewy Appoints Chris Deppe as Chief Financial Officer

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a leading and trusted destination for pet parents and partners everywhere, announced today the appointment of Chris Deppe as Chief Financial Officer (CFO). Deppe is a seasoned finance and operations leader with more than 20 years of experience. He joined Chewy in 2022 as the Vice President of Supply Chain and Operations Finance, and most recently served as the Head of all Corporate and Commercial Finance Functions. During his tenure, he has played a key role in advancing the company's financial strategy, enhancing operational rigor, and supporting strong business performance aligned with Chewy's long-term strategic priorities. Prior to joining Chewy, D

    2/24/26 9:00:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ACN
    $ADSK
    $CELH
    $CHWY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Toast Inc.

    SC 13G - Toast, Inc. (0001650164) (Subject)

    11/14/24 1:22:38 PM ET
    $TOST
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Toast Inc.

    SC 13G/A - Toast, Inc. (0001650164) (Subject)

    11/13/24 10:27:59 AM ET
    $TOST
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Sarepta Therapeutics Inc.

    SC 13G/A - Sarepta Therapeutics, Inc. (0000873303) (Subject)

    11/13/24 10:27:59 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care